Trials / Completed
CompletedNCT00449917
"Visiobiane Anti-age" Effects on Vision Parameters
Study of the Effects of "Visiobiane Anti-age" Dietary Supplement on Macular Pigment Optical Density, Contrast Sensibility and Visual Acuity
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (planned)
- Sponsor
- PiLeJe · Industry
- Sex
- Male
- Age
- 45 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the benefits of "Visiobiane Anti-age" dietary supplement on macular pigment optical density, contrast sensibility and visual acuity. Additionally, the study would like to evaluate seric variations of carotenoids and the total antioxydant capacity.
Detailed description
Visiobiane study is a randomized trial of 30 participants designed to assess the effects of oral supplementation of macular xanthophylls (lutein and zeaxanthin) and omega-3 LCPUFAs for the eyes protection. The study will enroll healthy participants aged 45 to 55 years. 15 subjects will be assigned in placebo group and 15 in experimetal group (Visiobiane anti-age). They will be supplemented for 24 weeks
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | lutein | |
| DRUG | DHA | |
| DRUG | vitamins |
Timeline
- Start date
- 2006-09-01
- Primary completion
- 2007-07-01
- Completion
- 2007-11-01
- First posted
- 2007-03-21
- Last updated
- 2011-10-06
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00449917. Inclusion in this directory is not an endorsement.